Dr Alan Robin is the Associate Professor Ophthalmology and International Health, Johns Hopkins University and Adjunct Professor, University of Michigan. Dr. Robin developed the current technique for treating angle closure glaucoma and the class of alpha-agonists for the medical therapy of glaucoma. He was the principal investigator of the first modern prevalence study in India. He is a global expert on adherence to medical therapy for glaucoma.